A phase I, open-label, pharmacokinetic study measuring plasma exposure of a 20 mg single dose administration of rosuvastatin calcium to healthy Asian subjects living in the United States related to the pharmacokinetic data obtained from a Caucasian control group

Study identifier:D3560C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A phase I, open-label, pharmacokinetic study measuring plasma exposure of a 20 mg single dose administration of rosuvastatin calcium to healthy Asian subjects living in the United States related to the pharmacokinetic data obtained from a Caucasian control group

Medical condition

hypercholesterolaemia

Phase

N/A

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria